nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—vein—stomach cancer	0.101	0.442	CbGeAlD
Tranexamic Acid—PLG—blood vessel—stomach cancer	0.032	0.14	CbGeAlD
Tranexamic Acid—PLG—hematopoietic system—stomach cancer	0.0171	0.0747	CbGeAlD
Tranexamic Acid—PLG—epithelium—stomach cancer	0.0156	0.0682	CbGeAlD
Tranexamic Acid—PLG—smooth muscle tissue—stomach cancer	0.015	0.0658	CbGeAlD
Tranexamic Acid—PLG—lymphoid tissue—stomach cancer	0.012	0.0526	CbGeAlD
Tranexamic Acid—PLG—digestive system—stomach cancer	0.0119	0.0519	CbGeAlD
Tranexamic Acid—PLG—endocrine gland—stomach cancer	0.0098	0.0429	CbGeAlD
Tranexamic Acid—PLG—liver—stomach cancer	0.00884	0.0387	CbGeAlD
Tranexamic Acid—PLG—Platelet degranulation—FGG—stomach cancer	0.00346	0.00944	CbGpPWpGaD
Tranexamic Acid—PLG—Regulation of IGF Activity by IGFBP—MMP2—stomach cancer	0.00342	0.00933	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—FGG—stomach cancer	0.0033	0.00899	CbGpPWpGaD
Tranexamic Acid—PLG—Blood Clotting Cascade—SERPINE1—stomach cancer	0.00323	0.00882	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—PPIA—stomach cancer	0.00314	0.00856	CbGpPWpGaD
Tranexamic Acid—SLC15A2—endocrine gland—stomach cancer	0.00313	0.0137	CbGeAlD
Tranexamic Acid—PLG—amb2 Integrin signaling—PLAU—stomach cancer	0.0031	0.00845	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CTSL—stomach cancer	0.00303	0.00827	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—SERPINA1—stomach cancer	0.00303	0.00825	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—PPIA—stomach cancer	0.00299	0.00816	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—ALOX5—stomach cancer	0.00298	0.00813	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SERPINA1—stomach cancer	0.00288	0.00786	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ICAM2—stomach cancer	0.00284	0.00776	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—SPARC—stomach cancer	0.00274	0.00746	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SPARC—stomach cancer	0.00261	0.00711	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD2—stomach cancer	0.00257	0.007	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—FYN—stomach cancer	0.00254	0.00693	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—stomach cancer	0.00249	0.0068	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP2—stomach cancer	0.00244	0.00666	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP2—stomach cancer	0.00244	0.00666	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP10—stomach cancer	0.00232	0.00632	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—RHOA—stomach cancer	0.00231	0.0063	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—RHOA—stomach cancer	0.00231	0.0063	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—MTHFR—stomach cancer	0.00226	0.00616	CbGpPWpGaD
Tranexamic Acid—SLC15A2—lymph node—stomach cancer	0.00217	0.00949	CbGeAlD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CD44—stomach cancer	0.00214	0.00583	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—stomach cancer	0.00211	0.00576	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—BDNF—stomach cancer	0.0021	0.00573	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—SOD2—stomach cancer	0.00209	0.00569	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—APOA1—stomach cancer	0.00208	0.00567	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00193	0.00526	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—stomach cancer	0.00193	0.00526	CbGpPWpGaD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—PLAU—stomach cancer	0.0019	0.00518	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—MTHFR—stomach cancer	0.00184	0.00501	CbGpPWpGaD
Tranexamic Acid—PLG—Syndecan-4-mediated signaling events—MMP9—stomach cancer	0.00184	0.00501	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—MMP9—stomach cancer	0.00184	0.00501	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—MMP9—stomach cancer	0.00184	0.00501	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MMP2—stomach cancer	0.00171	0.00466	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—APOA1—stomach cancer	0.00169	0.00461	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGA5—stomach cancer	0.00169	0.00461	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD2—stomach cancer	0.00166	0.00452	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SERPINE1—stomach cancer	0.00165	0.0045	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—ALB—stomach cancer	0.00165	0.00449	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGA8—stomach cancer	0.00163	0.00446	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—NOS3—stomach cancer	0.0016	0.00437	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—DPAGT1—stomach cancer	0.00156	0.00426	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—NOP56—stomach cancer	0.00156	0.00426	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—FGG—stomach cancer	0.00154	0.00419	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—BMP7—stomach cancer	0.00149	0.00407	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—stomach cancer	0.00148	0.00403	CbGpPWpGaD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—SERPINE1—stomach cancer	0.00147	0.00401	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—MTHFR—stomach cancer	0.00146	0.00398	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—APOA1—stomach cancer	0.00145	0.00395	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EEF1A2—stomach cancer	0.00143	0.0039	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—TNF—stomach cancer	0.00141	0.00385	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PPIA—stomach cancer	0.00139	0.0038	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—APOA1—stomach cancer	0.00138	0.00377	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—APOA1—stomach cancer	0.00134	0.00366	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—SERPINE1—stomach cancer	0.00134	0.00366	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SERPINA1—stomach cancer	0.00134	0.00366	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL1B—stomach cancer	0.00134	0.00366	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—ALB—stomach cancer	0.00134	0.00365	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FGG—stomach cancer	0.00133	0.00363	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MUC6—stomach cancer	0.00133	0.00363	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—PRKCB—stomach cancer	0.00132	0.00359	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—stomach cancer	0.00128	0.00349	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CTSL—stomach cancer	0.00127	0.00346	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—RHOA—stomach cancer	0.00125	0.00341	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK8—stomach cancer	0.00125	0.00341	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—F2R—stomach cancer	0.00121	0.00331	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SPARC—stomach cancer	0.00121	0.00331	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—stomach cancer	0.00119	0.00325	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CCT7—stomach cancer	0.00119	0.00323	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINB2—stomach cancer	0.00117	0.00319	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—SERPINE1—stomach cancer	0.00115	0.00314	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—ALB—stomach cancer	0.00115	0.00313	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—IL6—stomach cancer	0.00114	0.00311	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—HBEGF—stomach cancer	0.00113	0.00309	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—TUBA1C—stomach cancer	0.00113	0.00308	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EEF1A1—stomach cancer	0.00113	0.00308	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CDH1—stomach cancer	0.00112	0.00305	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.0011	0.00301	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SERPINE1—stomach cancer	0.0011	0.00299	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—ALB—stomach cancer	0.00109	0.00299	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK3—stomach cancer	0.00109	0.00298	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL1B—stomach cancer	0.00109	0.00297	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP2—stomach cancer	0.00108	0.00294	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.00107	0.00291	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—ALB—stomach cancer	0.00106	0.0029	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—SPARC—stomach cancer	0.00105	0.00287	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—BMP2—stomach cancer	0.00105	0.00287	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK1—stomach cancer	0.00104	0.00283	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ITGA5—stomach cancer	0.00101	0.00274	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—stomach cancer	0.000988	0.0027	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EXOSC5—stomach cancer	0.000976	0.00266	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—stomach cancer	0.000973	0.00265	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—MAPK8—stomach cancer	0.000965	0.00263	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000944	0.00257	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—stomach cancer	0.000931	0.00254	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FYN—stomach cancer	0.000904	0.00246	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—stomach cancer	0.000901	0.00246	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CD44—stomach cancer	0.000895	0.00244	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL1B—stomach cancer	0.000867	0.00236	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGFR2—stomach cancer	0.000848	0.00231	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.00084	0.00229	CbGpPWpGaD
Tranexamic Acid—Abdominal discomfort—Capecitabine—stomach cancer	0.000832	0.00205	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—CDX2—stomach cancer	0.000821	0.00224	CbGpPWpGaD
Tranexamic Acid—Malaise—Irinotecan—stomach cancer	0.000814	0.00201	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—stomach cancer	0.00081	0.00221	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPL18—stomach cancer	0.000806	0.0022	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPL13—stomach cancer	0.000806	0.0022	CbGpPWpGaD
Tranexamic Acid—Anaemia—Fluorouracil—stomach cancer	0.0008	0.00197	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Irinotecan—stomach cancer	0.000794	0.00196	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Doxorubicin—stomach cancer	0.000793	0.00196	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—stomach cancer	0.000792	0.00216	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TNF—stomach cancer	0.000792	0.00216	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—FGG—stomach cancer	0.000791	0.00216	CbGpPWpGaD
Tranexamic Acid—Visual disturbance—Methotrexate—stomach cancer	0.000789	0.00195	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Docetaxel—stomach cancer	0.000788	0.00195	CcSEcCtD
Tranexamic Acid—Renal failure—Docetaxel—stomach cancer	0.000785	0.00194	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—stomach cancer	0.000785	0.00214	CbGpPWpGaD
Tranexamic Acid—Myocardial infarction—Docetaxel—stomach cancer	0.000783	0.00193	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IRS2—stomach cancer	0.000777	0.00212	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—THBD—stomach cancer	0.000776	0.00212	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—FYN—stomach cancer	0.000774	0.00211	CbGpPWpGaD
Tranexamic Acid—Anaphylactoid reaction—Methotrexate—stomach cancer	0.000772	0.00191	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Capecitabine—stomach cancer	0.000763	0.00188	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Methotrexate—stomach cancer	0.000763	0.00188	CcSEcCtD
Tranexamic Acid—Renal failure—Capecitabine—stomach cancer	0.00076	0.00188	CcSEcCtD
Tranexamic Acid—Discomfort—Irinotecan—stomach cancer	0.00076	0.00188	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Capecitabine—stomach cancer	0.000758	0.00187	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—stomach cancer	0.000754	0.00206	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPS15—stomach cancer	0.000751	0.00205	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPS21—stomach cancer	0.000751	0.00205	CbGpPWpGaD
Tranexamic Acid—Convulsion—Fluorouracil—stomach cancer	0.000749	0.00185	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Irinotecan—stomach cancer	0.000737	0.00182	CcSEcCtD
Tranexamic Acid—Myalgia—Fluorouracil—stomach cancer	0.000736	0.00182	CcSEcCtD
Tranexamic Acid—Chest pain—Fluorouracil—stomach cancer	0.000736	0.00182	CcSEcCtD
Tranexamic Acid—Discomfort—Fluorouracil—stomach cancer	0.000728	0.0018	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Irinotecan—stomach cancer	0.000723	0.00179	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000723	0.00178	CcSEcCtD
Tranexamic Acid—Haemoglobin—Docetaxel—stomach cancer	0.000721	0.00178	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PPIA—stomach cancer	0.000718	0.00196	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Docetaxel—stomach cancer	0.000717	0.00177	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6ST—stomach cancer	0.000714	0.00195	CbGpPWpGaD
Tranexamic Acid—Cerebrovascular accident—Epirubicin—stomach cancer	0.000714	0.00176	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Fluorouracil—stomach cancer	0.000706	0.00174	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—MUC2—stomach cancer	0.000698	0.0019	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Capecitabine—stomach cancer	0.000698	0.00172	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—TP53—stomach cancer	0.000698	0.0019	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—stomach cancer	0.000696	0.0019	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Capecitabine—stomach cancer	0.000694	0.00172	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Fluorouracil—stomach cancer	0.000692	0.00171	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—SERPINA1—stomach cancer	0.000692	0.00189	CbGpPWpGaD
Tranexamic Acid—Visual impairment—Docetaxel—stomach cancer	0.000691	0.00171	CcSEcCtD
Tranexamic Acid—Hypotension—Irinotecan—stomach cancer	0.000689	0.0017	CcSEcCtD
Tranexamic Acid—Migraine—Epirubicin—stomach cancer	0.000688	0.0017	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—stomach cancer	0.000673	0.00184	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Docetaxel—stomach cancer	0.00067	0.00166	CcSEcCtD
Tranexamic Acid—Visual impairment—Capecitabine—stomach cancer	0.000669	0.00165	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000669	0.00165	CcSEcCtD
Tranexamic Acid—Flushing—Docetaxel—stomach cancer	0.000666	0.00164	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Docetaxel—stomach cancer	0.000666	0.00164	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Doxorubicin—stomach cancer	0.00066	0.00163	CcSEcCtD
Tranexamic Acid—Hypotension—Fluorouracil—stomach cancer	0.00066	0.00163	CcSEcCtD
Tranexamic Acid—Dyspnoea—Irinotecan—stomach cancer	0.000657	0.00162	CcSEcCtD
Tranexamic Acid—Angiopathy—Docetaxel—stomach cancer	0.000651	0.00161	CcSEcCtD
Tranexamic Acid—Eye disorder—Capecitabine—stomach cancer	0.000649	0.0016	CcSEcCtD
Tranexamic Acid—Dyspepsia—Irinotecan—stomach cancer	0.000649	0.0016	CcSEcCtD
Tranexamic Acid—Immune system disorder—Docetaxel—stomach cancer	0.000648	0.0016	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Docetaxel—stomach cancer	0.000646	0.0016	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Capecitabine—stomach cancer	0.000644	0.00159	CcSEcCtD
Tranexamic Acid—Flushing—Capecitabine—stomach cancer	0.000644	0.00159	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—APOA1—stomach cancer	0.000643	0.00175	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000643	0.00159	CcSEcCtD
Tranexamic Acid—Arrhythmia—Docetaxel—stomach cancer	0.000641	0.00158	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IL6—stomach cancer	0.000639	0.00174	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IL6R—stomach cancer	0.000637	0.00174	CbGpPWpGaD
Tranexamic Acid—Migraine—Doxorubicin—stomach cancer	0.000637	0.00157	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000636	0.00157	CcSEcCtD
Tranexamic Acid—Fatigue—Irinotecan—stomach cancer	0.000636	0.00157	CcSEcCtD
Tranexamic Acid—Angiopathy—Capecitabine—stomach cancer	0.00063	0.00156	CcSEcCtD
Tranexamic Acid—Dyspnoea—Fluorouracil—stomach cancer	0.000629	0.00155	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—stomach cancer	0.000629	0.00171	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Capecitabine—stomach cancer	0.000627	0.00155	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Capecitabine—stomach cancer	0.000626	0.00155	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—F2R—stomach cancer	0.000626	0.00171	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SPARC—stomach cancer	0.000626	0.00171	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Fluorouracil—stomach cancer	0.000621	0.00154	CcSEcCtD
Tranexamic Acid—Arrhythmia—Capecitabine—stomach cancer	0.00062	0.00153	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Methotrexate—stomach cancer	0.000619	0.00153	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	0.000614	0.00167	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IRF1—stomach cancer	0.000612	0.00167	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPL15—stomach cancer	0.000611	0.00166	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—HSPD1—stomach cancer	0.000611	0.00166	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00061	0.00151	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Irinotecan—stomach cancer	0.000607	0.0015	CcSEcCtD
Tranexamic Acid—Back pain—Docetaxel—stomach cancer	0.000604	0.00149	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Irinotecan—stomach cancer	0.000603	0.00149	CcSEcCtD
Tranexamic Acid—Muscle spasms—Docetaxel—stomach cancer	0.0006	0.00148	CcSEcCtD
Tranexamic Acid—Angina pectoris—Epirubicin—stomach cancer	0.000589	0.00145	CcSEcCtD
Tranexamic Acid—Back pain—Capecitabine—stomach cancer	0.000585	0.00144	CcSEcCtD
Tranexamic Acid—Abdominal pain—Irinotecan—stomach cancer	0.000583	0.00144	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Fluorouracil—stomach cancer	0.000582	0.00144	CcSEcCtD
Tranexamic Acid—Muscle spasms—Capecitabine—stomach cancer	0.000581	0.00144	CcSEcCtD
Tranexamic Acid—Anaemia—Docetaxel—stomach cancer	0.000577	0.00143	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—RPS26—stomach cancer	0.000569	0.00155	CbGpPWpGaD
Tranexamic Acid—Renal failure—Methotrexate—stomach cancer	0.000566	0.0014	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Capecitabine—stomach cancer	0.000561	0.00139	CcSEcCtD
Tranexamic Acid—Anaemia—Capecitabine—stomach cancer	0.000559	0.00138	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Docetaxel—stomach cancer	0.000549	0.00136	CcSEcCtD
Tranexamic Acid—Malaise—Capecitabine—stomach cancer	0.000545	0.00135	CcSEcCtD
Tranexamic Acid—Angina pectoris—Doxorubicin—stomach cancer	0.000545	0.00135	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Irinotecan—stomach cancer	0.000543	0.00134	CcSEcCtD
Tranexamic Acid—Convulsion—Docetaxel—stomach cancer	0.000541	0.00134	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—stomach cancer	0.000533	0.00145	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CD44—stomach cancer	0.000532	0.00145	CbGpPWpGaD
Tranexamic Acid—Myalgia—Docetaxel—stomach cancer	0.000532	0.00131	CcSEcCtD
Tranexamic Acid—Arthralgia—Docetaxel—stomach cancer	0.000532	0.00131	CcSEcCtD
Tranexamic Acid—Chest pain—Docetaxel—stomach cancer	0.000532	0.00131	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Capecitabine—stomach cancer	0.000531	0.00131	CcSEcCtD
Tranexamic Acid—Renal failure—Epirubicin—stomach cancer	0.00053	0.00131	CcSEcCtD
Tranexamic Acid—Asthenia—Irinotecan—stomach cancer	0.000529	0.00131	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Fluorouracil—stomach cancer	0.00052	0.00128	CcSEcCtD
Tranexamic Acid—Haemoglobin—Methotrexate—stomach cancer	0.00052	0.00128	CcSEcCtD
Tranexamic Acid—Haemorrhage—Methotrexate—stomach cancer	0.000517	0.00128	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—IGFBP3—stomach cancer	0.000516	0.00141	CbGpPWpGaD
Tranexamic Acid—Myalgia—Capecitabine—stomach cancer	0.000515	0.00127	CcSEcCtD
Tranexamic Acid—Chest pain—Capecitabine—stomach cancer	0.000515	0.00127	CcSEcCtD
Tranexamic Acid—Arthralgia—Capecitabine—stomach cancer	0.000515	0.00127	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GLI3—stomach cancer	0.000511	0.00139	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KISS1R—stomach cancer	0.000511	0.00139	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	0.000511	0.00139	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—stomach cancer	0.00051	0.00139	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Docetaxel—stomach cancer	0.00051	0.00126	CcSEcCtD
Tranexamic Acid—Discomfort—Capecitabine—stomach cancer	0.000508	0.00126	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—stomach cancer	0.000507	0.00138	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Epirubicin—stomach cancer	0.000506	0.00125	CcSEcCtD
Tranexamic Acid—Diarrhoea—Irinotecan—stomach cancer	0.000504	0.00125	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Docetaxel—stomach cancer	0.0005	0.00123	CcSEcCtD
Tranexamic Acid—Visual impairment—Methotrexate—stomach cancer	0.000498	0.00123	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1B—stomach cancer	0.000493	0.00135	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RHOA—stomach cancer	0.000493	0.00134	CbGpPWpGaD
Tranexamic Acid—Renal failure—Doxorubicin—stomach cancer	0.00049	0.00121	CcSEcCtD
Tranexamic Acid—Dizziness—Irinotecan—stomach cancer	0.000487	0.0012	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RBP1—stomach cancer	0.000487	0.00133	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Epirubicin—stomach cancer	0.000486	0.0012	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—RPS19—stomach cancer	0.000484	0.00132	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Capecitabine—stomach cancer	0.000484	0.0012	CcSEcCtD
Tranexamic Acid—Haemorrhage—Epirubicin—stomach cancer	0.000484	0.00119	CcSEcCtD
Tranexamic Acid—Eye disorder—Methotrexate—stomach cancer	0.000483	0.00119	CcSEcCtD
Tranexamic Acid—Diarrhoea—Fluorouracil—stomach cancer	0.000483	0.00119	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Methotrexate—stomach cancer	0.00048	0.00119	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.00048	0.00131	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—PAX6—stomach cancer	0.000479	0.00131	CbGpPWpGaD
Tranexamic Acid—Hypotension—Docetaxel—stomach cancer	0.000476	0.00118	CcSEcCtD
Tranexamic Acid—Angiopathy—Methotrexate—stomach cancer	0.000469	0.00116	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—stomach cancer	0.000469	0.00128	CbGpPWpGaD
Tranexamic Acid—Vomiting—Irinotecan—stomach cancer	0.000469	0.00116	CcSEcCtD
Tranexamic Acid—Sinusitis—Doxorubicin—stomach cancer	0.000468	0.00116	CcSEcCtD
Tranexamic Acid—Immune system disorder—Methotrexate—stomach cancer	0.000467	0.00115	CcSEcCtD
Tranexamic Acid—Dizziness—Fluorouracil—stomach cancer	0.000467	0.00115	CcSEcCtD
Tranexamic Acid—Visual impairment—Epirubicin—stomach cancer	0.000466	0.00115	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Methotrexate—stomach cancer	0.000466	0.00115	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000464	0.00115	CcSEcCtD
Tranexamic Acid—Headache—Irinotecan—stomach cancer	0.000462	0.00114	CcSEcCtD
Tranexamic Acid—Hypotension—Capecitabine—stomach cancer	0.000461	0.00114	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1A—stomach cancer	0.000455	0.00124	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Docetaxel—stomach cancer	0.000454	0.00112	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PPP2R1A—stomach cancer	0.000452	0.00123	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Epirubicin—stomach cancer	0.000452	0.00112	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP2—stomach cancer	0.000451	0.00123	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Doxorubicin—stomach cancer	0.00045	0.00111	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000449	0.00111	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Epirubicin—stomach cancer	0.000449	0.00111	CcSEcCtD
Tranexamic Acid—Flushing—Epirubicin—stomach cancer	0.000449	0.00111	CcSEcCtD
Tranexamic Acid—Vomiting—Fluorouracil—stomach cancer	0.000449	0.00111	CcSEcCtD
Tranexamic Acid—Dyspepsia—Docetaxel—stomach cancer	0.000449	0.00111	CcSEcCtD
Tranexamic Acid—Haemorrhage—Doxorubicin—stomach cancer	0.000448	0.00111	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—SERPINE1—stomach cancer	0.000443	0.00121	CbGpPWpGaD
Tranexamic Acid—Headache—Fluorouracil—stomach cancer	0.000442	0.00109	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00044	0.00109	CcSEcCtD
Tranexamic Acid—Dyspnoea—Capecitabine—stomach cancer	0.00044	0.00109	CcSEcCtD
Tranexamic Acid—Fatigue—Docetaxel—stomach cancer	0.000439	0.00109	CcSEcCtD
Tranexamic Acid—Angiopathy—Epirubicin—stomach cancer	0.000439	0.00108	CcSEcCtD
Tranexamic Acid—Nausea—Irinotecan—stomach cancer	0.000438	0.00108	CcSEcCtD
Tranexamic Acid—Immune system disorder—Epirubicin—stomach cancer	0.000437	0.00108	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Epirubicin—stomach cancer	0.000436	0.00108	CcSEcCtD
Tranexamic Acid—Back pain—Methotrexate—stomach cancer	0.000435	0.00108	CcSEcCtD
Tranexamic Acid—Dyspepsia—Capecitabine—stomach cancer	0.000434	0.00107	CcSEcCtD
Tranexamic Acid—Arrhythmia—Epirubicin—stomach cancer	0.000432	0.00107	CcSEcCtD
Tranexamic Acid—Visual impairment—Doxorubicin—stomach cancer	0.000431	0.00107	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—RPS6—stomach cancer	0.000428	0.00117	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000426	0.00105	CcSEcCtD
Tranexamic Acid—Fatigue—Capecitabine—stomach cancer	0.000425	0.00105	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ACE—stomach cancer	0.000425	0.00116	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Docetaxel—stomach cancer	0.00042	0.00104	CcSEcCtD
Tranexamic Acid—Nausea—Fluorouracil—stomach cancer	0.000419	0.00104	CcSEcCtD
Tranexamic Acid—Eye disorder—Doxorubicin—stomach cancer	0.000418	0.00103	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Methotrexate—stomach cancer	0.000418	0.00103	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Docetaxel—stomach cancer	0.000417	0.00103	CcSEcCtD
Tranexamic Acid—Anaemia—Methotrexate—stomach cancer	0.000416	0.00103	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—stomach cancer	0.000415	0.00103	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—stomach cancer	0.000415	0.00103	CcSEcCtD
Tranexamic Acid—Back pain—Epirubicin—stomach cancer	0.000407	0.00101	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Capecitabine—stomach cancer	0.000407	0.001	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—stomach cancer	0.000406	0.00111	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Doxorubicin—stomach cancer	0.000406	0.001	CcSEcCtD
Tranexamic Acid—Malaise—Methotrexate—stomach cancer	0.000406	0.001	CcSEcCtD
Tranexamic Acid—Muscle spasms—Epirubicin—stomach cancer	0.000405	0.001	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—stomach cancer	0.000404	0.000999	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Capecitabine—stomach cancer	0.000403	0.000996	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—stomach cancer	0.000403	0.000996	CcSEcCtD
Tranexamic Acid—Abdominal pain—Docetaxel—stomach cancer	0.000403	0.000995	CcSEcCtD
Tranexamic Acid—Arrhythmia—Doxorubicin—stomach cancer	0.0004	0.000988	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—FYN—stomach cancer	0.000399	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—WWOX—stomach cancer	0.000397	0.00108	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Epirubicin—stomach cancer	0.000391	0.000965	CcSEcCtD
Tranexamic Acid—Abdominal pain—Capecitabine—stomach cancer	0.00039	0.000963	CcSEcCtD
Tranexamic Acid—Convulsion—Methotrexate—stomach cancer	0.00039	0.000963	CcSEcCtD
Tranexamic Acid—Anaemia—Epirubicin—stomach cancer	0.000389	0.000961	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—stomach cancer	0.000388	0.00106	CbGpPWpGaD
Tranexamic Acid—Myalgia—Methotrexate—stomach cancer	0.000383	0.000946	CcSEcCtD
Tranexamic Acid—Arthralgia—Methotrexate—stomach cancer	0.000383	0.000946	CcSEcCtD
Tranexamic Acid—Chest pain—Methotrexate—stomach cancer	0.000383	0.000946	CcSEcCtD
Tranexamic Acid—Malaise—Epirubicin—stomach cancer	0.00038	0.000938	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000379	0.00103	CbGpPWpGaD
Tranexamic Acid—Discomfort—Methotrexate—stomach cancer	0.000379	0.000935	CcSEcCtD
Tranexamic Acid—Back pain—Doxorubicin—stomach cancer	0.000377	0.000931	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Docetaxel—stomach cancer	0.000375	0.000927	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—stomach cancer	0.000375	0.000925	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Epirubicin—stomach cancer	0.00037	0.000914	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK1—stomach cancer	0.000369	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—WIF1—stomach cancer	0.000369	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRH4—stomach cancer	0.000369	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—stomach cancer	0.000369	0.00101	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Methotrexate—stomach cancer	0.000367	0.000907	CcSEcCtD
Tranexamic Acid—Asthenia—Docetaxel—stomach cancer	0.000366	0.000903	CcSEcCtD
Tranexamic Acid—Convulsion—Epirubicin—stomach cancer	0.000365	0.000901	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Capecitabine—stomach cancer	0.000363	0.000898	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—stomach cancer	0.000362	0.000893	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Methotrexate—stomach cancer	0.00036	0.00089	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—stomach cancer	0.00036	0.00089	CcSEcCtD
Tranexamic Acid—Chest pain—Epirubicin—stomach cancer	0.000359	0.000886	CcSEcCtD
Tranexamic Acid—Myalgia—Epirubicin—stomach cancer	0.000359	0.000886	CcSEcCtD
Tranexamic Acid—Arthralgia—Epirubicin—stomach cancer	0.000359	0.000886	CcSEcCtD
Tranexamic Acid—Discomfort—Epirubicin—stomach cancer	0.000354	0.000875	CcSEcCtD
Tranexamic Acid—Asthenia—Capecitabine—stomach cancer	0.000354	0.000874	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—stomach cancer	0.000351	0.000868	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	0.000351	0.000958	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—stomach cancer	0.000349	0.000951	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Docetaxel—stomach cancer	0.000349	0.000861	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Epirubicin—stomach cancer	0.000344	0.000849	CcSEcCtD
Tranexamic Acid—Hypotension—Methotrexate—stomach cancer	0.000343	0.000848	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Doxorubicin—stomach cancer	0.000342	0.000846	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PRKAB1—stomach cancer	0.000341	0.000929	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PLAU—stomach cancer	0.00034	0.000928	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—stomach cancer	0.000339	0.000925	CbGpPWpGaD
Tranexamic Acid—Convulsion—Doxorubicin—stomach cancer	0.000338	0.000834	CcSEcCtD
Tranexamic Acid—Diarrhoea—Capecitabine—stomach cancer	0.000338	0.000834	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Epirubicin—stomach cancer	0.000337	0.000833	CcSEcCtD
Tranexamic Acid—Dizziness—Docetaxel—stomach cancer	0.000337	0.000832	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000335	0.000827	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CAV1—stomach cancer	0.000332	0.000906	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	0.000332	0.000906	CbGpPWpGaD
Tranexamic Acid—Myalgia—Doxorubicin—stomach cancer	0.000332	0.000819	CcSEcCtD
Tranexamic Acid—Chest pain—Doxorubicin—stomach cancer	0.000332	0.000819	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—stomach cancer	0.000332	0.000819	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—APOA1—stomach cancer	0.000332	0.000904	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RNF43—stomach cancer	0.000329	0.000898	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KISS1—stomach cancer	0.000329	0.000898	CbGpPWpGaD
Tranexamic Acid—Discomfort—Doxorubicin—stomach cancer	0.000328	0.00081	CcSEcCtD
Tranexamic Acid—Dyspnoea—Methotrexate—stomach cancer	0.000327	0.000809	CcSEcCtD
Tranexamic Acid—Dizziness—Capecitabine—stomach cancer	0.000326	0.000806	CcSEcCtD
Tranexamic Acid—Vomiting—Docetaxel—stomach cancer	0.000324	0.0008	CcSEcCtD
Tranexamic Acid—Dyspepsia—Methotrexate—stomach cancer	0.000323	0.000799	CcSEcCtD
Tranexamic Acid—Hypotension—Epirubicin—stomach cancer	0.000321	0.000793	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—stomach cancer	0.00032	0.000874	CbGpPWpGaD
Tranexamic Acid—Headache—Docetaxel—stomach cancer	0.000319	0.000789	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—stomach cancer	0.000318	0.000786	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000317	0.000783	CcSEcCtD
Tranexamic Acid—Fatigue—Methotrexate—stomach cancer	0.000317	0.000782	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PRKCB—stomach cancer	0.000316	0.000863	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	0.000316	0.000862	CbGpPWpGaD
Tranexamic Acid—Vomiting—Capecitabine—stomach cancer	0.000314	0.000775	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000313	0.000773	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Doxorubicin—stomach cancer	0.000312	0.00077	CcSEcCtD
Tranexamic Acid—Headache—Capecitabine—stomach cancer	0.000309	0.000763	CcSEcCtD
Tranexamic Acid—Dyspnoea—Epirubicin—stomach cancer	0.000306	0.000757	CcSEcCtD
Tranexamic Acid—Nausea—Docetaxel—stomach cancer	0.000303	0.000748	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Methotrexate—stomach cancer	0.000303	0.000748	CcSEcCtD
Tranexamic Acid—Dyspepsia—Epirubicin—stomach cancer	0.000303	0.000747	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Methotrexate—stomach cancer	0.0003	0.000742	CcSEcCtD
Tranexamic Acid—Hypotension—Doxorubicin—stomach cancer	0.000297	0.000734	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000297	0.000733	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—HRAS—stomach cancer	0.000296	0.000808	CbGpPWpGaD
Tranexamic Acid—Fatigue—Epirubicin—stomach cancer	0.000296	0.000732	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FST—stomach cancer	0.000293	0.0008	CbGpPWpGaD
Tranexamic Acid—Nausea—Capecitabine—stomach cancer	0.000293	0.000724	CcSEcCtD
Tranexamic Acid—Abdominal pain—Methotrexate—stomach cancer	0.00029	0.000717	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00029	0.000716	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000287	0.000783	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—stomach cancer	0.000284	0.000774	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Doxorubicin—stomach cancer	0.000284	0.0007	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Epirubicin—stomach cancer	0.000283	0.0007	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RGS2—stomach cancer	0.000283	0.000772	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GAST—stomach cancer	0.000283	0.000772	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Epirubicin—stomach cancer	0.000281	0.000694	CcSEcCtD
Tranexamic Acid—Dyspepsia—Doxorubicin—stomach cancer	0.00028	0.000691	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000275	0.000678	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	0.000274	0.000748	CbGpPWpGaD
Tranexamic Acid—Fatigue—Doxorubicin—stomach cancer	0.000274	0.000677	CcSEcCtD
Tranexamic Acid—Abdominal pain—Epirubicin—stomach cancer	0.000272	0.000671	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Methotrexate—stomach cancer	0.000271	0.000668	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FGG—stomach cancer	0.000268	0.000732	CbGpPWpGaD
Tranexamic Acid—Asthenia—Methotrexate—stomach cancer	0.000264	0.000651	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—SERPINE1—stomach cancer	0.000263	0.000718	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ALB—stomach cancer	0.000263	0.000716	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Doxorubicin—stomach cancer	0.000262	0.000647	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—stomach cancer	0.00026	0.000642	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PRKAA1—stomach cancer	0.000258	0.000704	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000255	0.000697	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RHOA—stomach cancer	0.000254	0.000692	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Epirubicin—stomach cancer	0.000253	0.000625	CcSEcCtD
Tranexamic Acid—Abdominal pain—Doxorubicin—stomach cancer	0.000251	0.000621	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—NOS3—stomach cancer	0.000251	0.000685	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Methotrexate—stomach cancer	0.000251	0.000621	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RBP4—stomach cancer	0.000249	0.00068	CbGpPWpGaD
Tranexamic Acid—Asthenia—Epirubicin—stomach cancer	0.000247	0.000609	CcSEcCtD
Tranexamic Acid—Dizziness—Methotrexate—stomach cancer	0.000243	0.0006	CcSEcCtD
Tranexamic Acid—Diarrhoea—Epirubicin—stomach cancer	0.000235	0.000581	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Doxorubicin—stomach cancer	0.000234	0.000579	CcSEcCtD
Tranexamic Acid—Vomiting—Methotrexate—stomach cancer	0.000234	0.000577	CcSEcCtD
Tranexamic Acid—Headache—Methotrexate—stomach cancer	0.00023	0.000568	CcSEcCtD
Tranexamic Acid—Asthenia—Doxorubicin—stomach cancer	0.000228	0.000564	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—stomach cancer	0.000227	0.00062	CbGpPWpGaD
Tranexamic Acid—Dizziness—Epirubicin—stomach cancer	0.000227	0.000561	CcSEcCtD
Tranexamic Acid—Vomiting—Epirubicin—stomach cancer	0.000219	0.00054	CcSEcCtD
Tranexamic Acid—Nausea—Methotrexate—stomach cancer	0.000218	0.000539	CcSEcCtD
Tranexamic Acid—Diarrhoea—Doxorubicin—stomach cancer	0.000218	0.000537	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000216	0.00059	CbGpPWpGaD
Tranexamic Acid—Headache—Epirubicin—stomach cancer	0.000215	0.000532	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HSPB1—stomach cancer	0.000214	0.000585	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGTR2—stomach cancer	0.000214	0.000585	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—F2R—stomach cancer	0.000212	0.000578	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BMP2—stomach cancer	0.000212	0.000578	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP2—stomach cancer	0.000211	0.000575	CbGpPWpGaD
Tranexamic Acid—Dizziness—Doxorubicin—stomach cancer	0.00021	0.000519	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—AKR1C3—stomach cancer	0.000209	0.000569	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HTR1A—stomach cancer	0.000206	0.000563	CbGpPWpGaD
Tranexamic Acid—Nausea—Epirubicin—stomach cancer	0.000204	0.000504	CcSEcCtD
Tranexamic Acid—Vomiting—Doxorubicin—stomach cancer	0.000202	0.000499	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ANXA1—stomach cancer	0.000199	0.000544	CbGpPWpGaD
Tranexamic Acid—Headache—Doxorubicin—stomach cancer	0.000199	0.000492	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ADRB1—stomach cancer	0.000193	0.000527	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—stomach cancer	0.000189	0.000467	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RPS6—stomach cancer	0.000184	0.000503	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—stomach cancer	0.000181	0.000494	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—stomach cancer	0.000175	0.000478	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MAPK3—stomach cancer	0.000171	0.000467	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HBEGF—stomach cancer	0.00017	0.000462	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000164	0.000447	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MAPK1—stomach cancer	0.000163	0.000444	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADRB2—stomach cancer	0.000156	0.000427	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KRAS—stomach cancer	0.000154	0.00042	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PPP2R1A—stomach cancer	0.000153	0.000418	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SMAD4—stomach cancer	0.000142	0.000388	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—stomach cancer	0.000141	0.000386	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—stomach cancer	0.000137	0.000373	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FYN—stomach cancer	0.000135	0.000369	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HRAS—stomach cancer	0.000131	0.000357	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—stomach cancer	0.00013	0.000354	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGFR2—stomach cancer	0.000127	0.000346	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IRS2—stomach cancer	0.000116	0.000317	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CAV1—stomach cancer	0.000113	0.000307	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOA1—stomach cancer	0.000112	0.000307	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRKCB—stomach cancer	0.000107	0.000292	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6ST—stomach cancer	0.000107	0.000291	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APC—stomach cancer	0.000103	0.00028	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6R—stomach cancer	9.53e-05	0.00026	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SERPINE1—stomach cancer	8.92e-05	0.000243	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RHOA—stomach cancer	8.61e-05	0.000235	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOS3—stomach cancer	8.52e-05	0.000232	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—stomach cancer	7.97e-05	0.000217	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—stomach cancer	7.56e-05	0.000206	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1B—stomach cancer	7.38e-05	0.000201	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—stomach cancer	7.04e-05	0.000192	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JUN—stomach cancer	7.03e-05	0.000192	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—stomach cancer	6.84e-05	0.000186	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1A—stomach cancer	6.81e-05	0.000186	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK8—stomach cancer	6.65e-05	0.000181	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—stomach cancer	6.14e-05	0.000167	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—stomach cancer	6.08e-05	0.000166	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—stomach cancer	5.81e-05	0.000158	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—stomach cancer	5.65e-05	0.000154	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK1—stomach cancer	5.52e-05	0.000151	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—stomach cancer	5.52e-05	0.000151	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—stomach cancer	5.22e-05	0.000142	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—stomach cancer	4.79e-05	0.000131	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—stomach cancer	4.64e-05	0.000126	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRAS—stomach cancer	4.44e-05	0.000121	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—stomach cancer	4.24e-05	0.000116	CbGpPWpGaD
